Page last updated: 2024-11-04

pseudooxynicotine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pseudooxynicotine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

pseudooxynicotine : An aminoacylpyridine that is pyridine substituted at position 3 by a 4-(methylamino)butanoyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID434
CHEMBL ID3544721
CHEBI ID37753
SCHEMBL ID5415831
MeSH IDM0217834

Synonyms (19)

Synonym
CHEBI:37753 ,
4-(methylamino)-1-(3-pyridinyl)-1-butanone
4-(methylamino)-1-(pyridin-3-yl)butan-1-one
2055-23-4
pseudooxynicotine
4-(methylamino)-1-(3-pyridyl)-1-butanone
4-(methylamino)-1-pyridin-3-ylbutan-1-one
C20361
1-butanone, 4-(methylamino)-1-(3-pyridinyl)-
unii-1njl277r65
1njl277r65 ,
FT-0671485
SCHEMBL5415831
DTXSID80174551
CHEMBL3544721
Q27117250
SY283926
mfcd09859673
EN300-8141092
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
pyridine alkaloid
aminoacylpyridine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's6 (66.67)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.68 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.35 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]